Back to search
Purpura, Schoenlein-Henoch
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Purpura, Schoenlein-Henoch trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Purpura, Schoenlein-Henoch trials you may qualify forThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy follow…
Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with…
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online…
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of…
The purpose of this study is to evaluate the safety and tolerability of atacicept in adult and adolescent participants and to measure the effect in reducing pro…
To further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this stud…
The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up b…